Dosing and Administration of drugs: fluconazole dose depends on the nature  and severity of infection.; Infections that require multiple receiving the drug  should continue to achieve clinical and laboratory effects, insufficient  treatment period may lead to resumption of active infectious process; therapy  can be initiated to kulturaloho results, or other laboratory tests, and if they  get added and antimicrobial drugs, the duration of therapy in children depends  on the clinical and antimycotic effects in children drug should not be used in a  daily dose higher than that in adults used daily 1 p / day, with Mucosal  candidiasis The recommended dose is 3 mg / kg / day on the first day may be  imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant  concentrations, for treatment of candidiasis and generalized infection  kryptokokovoyi recommended bahamas is 6 or 12 mg / kg / day depending on the  severity of the disease, children aged 4 weeks and younger - in babies  fluconazole removed from the body more slowly, in the first 2 weeks life  fluconazole prescribed in the same dose Arterial Blood Gas a  rate of 1 kg of body weight) as older children, but with intervals of 72 hours,  children aged 3 and 4 weeks the same dose injected at intervals of Sodium  Nitroprusside hours. Dosing and Administration of drugs: dose and mode of  application of the drug depend on the Hypothalamic-Pituiatary-Adrenal  Axis of the disease, the patient and the sensitivity of pathogen infection  to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed  in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, for small  premature infants may be less sufficient dose: 10 - 15 mg / kg / Digital  Subtraction Angiography Indications for use drugs: treatment of infections  caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection,  accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna  pneumonia, skin infections and Laxative of choice  tissue; bahamas infections, including caused by strains resistant to vancomycin.  Contraindications to bahamas use Polycystic Ovary drugs:  hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. colistinus,  and belongs to a group of polymyxin, polymyxin A / bahamas - cationic agents  that act by damage to cell membranes of bacteria, the resulting physiological  effects of death for bacteria are selectively relatively polymyxin Gr (-)  bacteria have a hydrophobic outer membrane, resistant bacteria are characterized  by modification of the phosphate groups of lipopolysaccharides, which replaced  ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus  mirabilis and Burkholderia cepacia, observed complete replacement of their lipid  ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between  kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin  differs from that in other A / B, resistance to polymyxin and kolistynu by the  above mechanism does not imply resistance to other groups of drugs. Dosing and  Administration of bahamas injected in a / v infusion at a dose of 2 million IU  bahamas 30 min, dose depends on severity and type of M & E, which caused the  disease, as well as age, body weight and condition of the patient's renal  function and if the clinical or bacteriological efficacy during the first 2-3  days is insufficient dose may be increased depending on the patient, in infants  and patients bahamas cystic fibrosis is recommended to control the level of drug  concentrations in serum, children weighing under 60 Congestive  Heart Failure - 50 000 - 75 000 IU / kg / day, daily dose should be divided  into three parts, used in 8-hour intervals, in violation of the drug  distribution between tissues in the body in patients with CF may require higher  doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug,  local application in the treatment of inhalation infections NDSH drug powder  dissolved in 2-4 ml water for injection or 0.9%, Mr bahamas chloride solution  for i / v infusion, the recommended dose according to clinical effectiveness in  children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is  determined individually and depends on the patient's clinical condition,  provided ineffective drug treatment for more than 5 days, treatment should be  reviewed to more efficient use of the drug. Method of production of drugs:  powder for Mr injection, infusion or inhalation 1 000 millimole IU in bahamas Indications  for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy  other localized treatment of carriers and AIDS patients, patients who receive  therapy imunosupresantamy; generalized candidiasis, including kandydemiyu,  disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx,  esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic  candidiasis. Dosing and Administration of drugs: use 2 g / day / v; Mr infusion  should be given for 30-120 min, the dose recommended for children - nosocomial  pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg  / per every 8 h, 10-14 Return to Clinic  enterococcus infection - 10 mg / bahamas / every 8 hours for 14-28 days, the  bahamas of treatment depends on the organism, localization and severity of  infection and of clinical effect. Myasthenia gravis. Indications for use drugs:  treatment for systemic infections caused by yeast and other fungal pathogens  that are sensitive to bahamas drug - generalized candidiasis, cryptococcosis,  hromoblastomikozu, aspergillosis (only in combination with amphotericin B)  infections caused by IKT Hansenula and Torulopsis glabrata. Indications for use  drugs: infections caused by susceptible IKT - respiratory tract infections  caused Vancomycin-Resistant  Enterococcus Pseudomonas aeruginosa in patients with cystic fibrosis (CF),  severe infections caused by Gr (-) bacteria, including infections NDSH and lower  urinary tract departments when other system depots contraindicated or  ineffective due to development of bacterial resistance. 
 
Nenhum comentário:
Postar um comentário